CD8A and neoplasm: A similar phenomenon has been reported for immunotherapy, in which liver metastases uniquely blunt checkpoint inhibitor response through hepatic macrophage-mediated elimination of CD8 T cells.47 A critical question emerging is why only certain tumours in the liver can trigger high RPLS scores leading to diminished chemotherapy response.